calu 6 Search Results


calu  (ATCC)
96
ATCC calu
Calu, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calu+6/Calu-6/10__1158_slash_1078___0432__ccr___04___1147-47-0-9
Average 96 stars, based on 1 article reviews
calu - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
calu 6  (CLS Cell Lines Service GmbH)
90
CLS Cell Lines Service GmbH calu 6
Calu 6, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calu+6/Calu-6+Cells/pm25353388-44-0-2
Average 90 stars, based on 1 article reviews
calu 6 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
calu 6 cells  (ATCC)
94
ATCC calu 6 cells
Calu 6 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calu+6/Calu-6%3B+Anaplastic+Carcinoma%3B+Human/us07071332-1980-27-31
Average 94 stars, based on 1 article reviews
calu 6 cells - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
calu 6  (DSMZ)
91
DSMZ calu 6
Calu 6, supplied by DSMZ, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calu+6/CALU-6/pm38160212-87-1-15
Average 91 stars, based on 1 article reviews
calu 6 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
calu6  (AstraZeneca ltd)
90
AstraZeneca ltd calu6
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Calu6, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calu+6/calu6/pmc04627780-209-8-35
Average 90 stars, based on 1 article reviews
calu6 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
protein extract of calu-6 cells  (Promega)
90
Promega protein extract of calu-6 cells
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Protein Extract Of Calu 6 Cells, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calu+6/protein+extract+of+calu+6+cells/10__1161_slash_01__res__0000059300__67152__4e-52-10-17
Average 90 stars, based on 1 article reviews
protein extract of calu-6 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
calu6  (Oncolead Inc)
90
Oncolead Inc calu6
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Calu6, supplied by Oncolead Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calu+6/calu6/pmc10320480-57-34-20
Average 90 stars, based on 1 article reviews
calu6 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
calu-6 cell line  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare calu-6 cell line
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Calu 6 Cell Line, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calu+6/calu+6+cell+line/pm33271249-58-3-14
Average 90 stars, based on 1 article reviews
calu-6 cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
calu 6  (Pasteur Institute)
86
Pasteur Institute calu 6
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Calu 6, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calu+6/6+calu/10__1016_slash_j__heliyon__2026__e44534-67-14-25
Average 86 stars, based on 1 article reviews
calu 6 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
calu 6 cell line  (Elabscience)
N/A
   Buy from Supplier
calu-6 cell complete medium  (Elabscience Biotechnology)
N/A
   Buy from Supplier
calu-6 cell line  (CancerTools Org)
N/A
This cell line was established in 1971 from lung metastasis in lung adenocarcinoma. CaLu-6 is a human lung adenocarcinoma cell line.
   Buy from Supplier

Image Search Results


Panels (A-B) show fits of the model for Calu6 and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.

Journal: PLoS Computational Biology

Article Title: Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical Approach

doi: 10.1371/journal.pcbi.1004550

Figure Lengend Snippet: Panels (A-B) show fits of the model for Calu6 and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.

Article Snippet: We stained tissue sections of the following tumours: Calu6 (n = 8), Calu3 (n = 7), one squamous cell lung cancer explant (n = 28) and squamous cell lung clinical cancers (n = 12) from AstraZeneca databanks.

Techniques: Immunohistochemistry

(A) Growth curve fit for 4 explant models, 2 for squamous lung carcinoma and 2 for colorectal carcinoma. The xenografted cell line Calu3 shows very similar behaviour to explant models. (B) Comparison between Calu6 and Calu3 lung cell lines; a squamous lung cancer explant; and clinical tumour material analyses. The bar chart shows the proportions of microvessel density (MVD) in area (quantified from CD31), necrosis (quantified from Hematoxylin & Eosin staining) and stroma (alpha smooth muscle actin (αSMA) positive staining). (C) Images of the different tumour models stained for αSMA and counter-stained with hematoxylin.

Journal: PLoS Computational Biology

Article Title: Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical Approach

doi: 10.1371/journal.pcbi.1004550

Figure Lengend Snippet: (A) Growth curve fit for 4 explant models, 2 for squamous lung carcinoma and 2 for colorectal carcinoma. The xenografted cell line Calu3 shows very similar behaviour to explant models. (B) Comparison between Calu6 and Calu3 lung cell lines; a squamous lung cancer explant; and clinical tumour material analyses. The bar chart shows the proportions of microvessel density (MVD) in area (quantified from CD31), necrosis (quantified from Hematoxylin & Eosin staining) and stroma (alpha smooth muscle actin (αSMA) positive staining). (C) Images of the different tumour models stained for αSMA and counter-stained with hematoxylin.

Article Snippet: We stained tissue sections of the following tumours: Calu6 (n = 8), Calu3 (n = 7), one squamous cell lung cancer explant (n = 28) and squamous cell lung clinical cancers (n = 12) from AstraZeneca databanks.

Techniques: Comparison, Staining

Parameter results ( k p and k R ′ ) for the ODM model in xenografts. Confidence intervals for each parameter are specified as well as the rank of the FIM (as a measure of the number of identifiable parameters), the collinearity index (Identifiable if γ <10), the condition number (Indentifiable if κ <1000) and the normalised residual. Cell lines denoted by * are unidentifiable and cell lines denoted by # are arguably identifiable.

Journal: PLoS Computational Biology

Article Title: Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical Approach

doi: 10.1371/journal.pcbi.1004550

Figure Lengend Snippet: Parameter results ( k p and k R ′ ) for the ODM model in xenografts. Confidence intervals for each parameter are specified as well as the rank of the FIM (as a measure of the number of identifiable parameters), the collinearity index (Identifiable if γ <10), the condition number (Indentifiable if κ <1000) and the normalised residual. Cell lines denoted by * are unidentifiable and cell lines denoted by # are arguably identifiable.

Article Snippet: We stained tissue sections of the following tumours: Calu6 (n = 8), Calu3 (n = 7), one squamous cell lung cancer explant (n = 28) and squamous cell lung clinical cancers (n = 12) from AstraZeneca databanks.

Techniques: